Indications and Purposes
| 1 Indications And Usage Mylotarg Is A Cd33-Directed Antibody And Cytotoxic Drug Conjugate Indicated For: Treatment Of Newly-Diagnosed Cd33-Positive Acute Myeloid Leukemia (Aml) In Adults And Pediatric Patients 1 Month And Older ( 1.1 ). Treatment Of Relapsed Or Refractory Cd33-Positive Aml In Adults And Pediatric Patients 2 Years And Older ( 1.2 ). 1.1 Newly-Diagnosed Cd33-Positive Acute Myeloid Leukemia (Aml) Mylotarg Is Indicated For The Treatment Of Newly-Diagnosed Cd33-Positive Acute Myeloid Leukemia In Adults And Pediatric Patients 1 Month And Older. 1.2 Relapsed Or Refractory Cd33-Positive Aml Mylotarg Is Indicated For The Treatment Of Relapsed Or Refractory Cd33-Positive Acute Myeloid Leukemia In Adults And Pediatric Patients 2 Years And Older. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Gemtuzumab Ozogamicin |